Oral drug absorption predictions using “in silico” models (SIMCYP®): Statins
Abstract
Using Simcyp® software, simulation studies were done in order to evaluate the capacity of this software to predict clinical evidence related to absorption profile of two statins: simvastatin and rosuvastatin. Specifically, we evaluate the influence of intestinal transit time, transporter abundance and enzymes responsible of metabolism in gastrointestinal tract. First of all we looked for bibliographic information about the absorption profile of these drugs. Then we carried out simulations in different population groups, mainly in normal populations, populations with accelerated intestinal transit and poor metabolizers. For rosuvastatin its efflux transporter (ABCG2) was also blocked and its permeability altered. The results are consistent with observations drawn from clinical experience. They show that the transit rate significantly affects the absorbed fraction of simvastatin, but not the rate of rosuvastatin; however the transporter abundance and permeability value are relevant in the absorption of rosuvastatin. CYP3A4 is shown as the most important isoenzyme responsible of the biotransformation of simvastatin, confirming that CYP3A4 does not participate in rosuvastatin intestinal metabolism.
- Referencias
- Cómo citar
- Del mismo autor
- Métricas
Similar Articles
- Marina Gorostiola, María José García Sánchez, María Dolores Santos Buelga, In silico prediction of drug absorption in celiac disease , FarmaJournal: Vol. 3 No. 1 (2018)
- Sandra Gomes Pereira, ASPECTS OF THE DEVELOPMENT OF NEW ANTI-LEISHMANIA DRUGS: FROM CONTROL OF NEGLECTED INFECTIONS TO PARASITE-HOST INTERACTIONS AND DRUG-RESISTANT PARASITES , FarmaJournal: Vol. 5 No. 1 (2020)
- Carlos Tapia Artiles, J. Samuel Pérez-Blanco, Dolores Santos Buelga, María José García Sánchez, Population pharmacokinetics of phenytoin in adult patients , FarmaJournal: Vol. 5 No. 2 (2020)
- Javier Iglesias Colino, David García González, Miriam Flores Fernández, Pilar González Pérez, Miguel García Sanz, Alejandro Sanz Ruiz, Juan José Ortiz De Urbina González, Therapeutic drug monitoring of serum concentrations of abiraterone , FarmaJournal: Vol. 11 No. 1 (2026)
- Sara Puebla Bravo, Nerea González García, Antonio Blázquez Zaballos, Study of the Relationship between Burnout Syndrome, Stress and Engagement in University Students , FarmaJournal: Vol. 9 No. 1 (2024)
- Irene Fernández Sánchez, Aránzazu Zarzuelo Castañeda, Cosmetic wipes for the treatment of hyperhidrosis without the presence of aluminum salts , FarmaJournal: Vol. 5 No. 1 (2020)
- Alejandro García, María Dolores Santos, In silico characterization of clozapine pharmacokinetics in different patient populations. , FarmaJournal: Vol. 4 No. 2 (2019)
- Luis Jesús Mastache Campelo, Julio Antonio Valdueza Beneitez, Miriam Rodriguez María, José Luis Ortiz De Urbina González, Implementation of a Secuential Therapy Program in Hospital of El Bierzo , FarmaJournal: Vol. 1 No. 2 (2016)
- Blanca Calderón García, María José De Jesús Valle, Lyophillization of Liposomes for Pulmonary Administration , FarmaJournal: Vol. 7 No. 2 (2022)
- Laura Garrido de Gracia, María José de Jesús Valle, Aránzazu Zarzuelo Castañeda, Amparo Sánchez Navarro, Development of Mucoadhesive Oral Formulations Based on Resveratrol Liposomes , FarmaJournal: Vol. 10 No. 2 (2025)
You may also start an advanced similarity search for this article.